Recombinant Human APOO Protein，His

APOO (Apolipoprotein O) is a member of the apolipoprotein family, which plays a crucial role in lipid metabolism and cardiovascular health. Research into the recombinant production of APOO protein has gained momentum due to its potential implications in understanding various metabolic disorders. APOO is primarily expressed in the liver and has been associated with the regulation of cholesterol and triglyceride levels, influencing the risk of cardiovascular diseases. Studies suggest that variations in APOO expression levels may contribute to the pathogenesis of conditions such as atherosclerosis and dyslipidemia. Moreover, recent findings indicate that APOO may interact with other key proteins involved in lipid transport and metabolism, further underscoring its significance in the lipid metabolic pathway. Recombinant techniques enable the mass production of APOO protein, facilitating in vitro studies and the exploration of its physiological functions and mechanisms of action. Understanding the structure and function of APOO through recombinant methods can provide insights into its role in health and disease, potentially leading to novel therapeutic approaches for managing lipid-related disorders. As research advances, the characterization of recombinant APOO will aid in elucidating its biological significance and pave the way for future studies aimed at translating these findings into clinical applications.